On Friday, Praxis Precision Medicines Inc (NASDAQ: PRAX) was 4.20% up from the session before settling in for the closing price of $188.54. A 52-week range for PRAX has been $26.70 – $206.71.
Annual sales at Healthcare sector company grew by 8.54% over the past five years. When this article was written, the company’s average yearly earnings per share was at -28.04%. With a float of $23.49 million, this company’s outstanding shares have now reached $25.01 million.
Praxis Precision Medicines Inc (PRAX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Praxis Precision Medicines Inc stocks. The insider ownership of Praxis Precision Medicines Inc is 6.06%, while institutional ownership is 89.31%. The most recent insider transaction that took place on Nov 20 ’25, was worth 4,852,256. In this transaction General Counsel and Secretary of this company sold 25,130 shares at a rate of $193.09, taking the stock ownership to the 20,832 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Principal Accounting Officer sold 13,600 for $192.08, making the entire transaction worth $2,612,244. This insider now owns 10,442 shares in total.
Praxis Precision Medicines Inc (PRAX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -2.94 earnings per share (EPS) during the time that was less than consensus figure (set at -2.82) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.16% during the next five years compared to 8.54% growth over the previous five years of trading.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators
You can see what Praxis Precision Medicines Inc (PRAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 658.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.90, a number that is poised to hit -3.09 in the next quarter and is forecasted to reach -12.71 in one year’s time.
Technical Analysis of Praxis Precision Medicines Inc (PRAX)
Praxis Precision Medicines Inc (NASDAQ: PRAX) saw its 5-day average volume 1.17 million, a positive change from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 80.25%.
During the past 100 days, Praxis Precision Medicines Inc’s (PRAX) raw stochastic average was set at 93.95%, which indicates a significant increase from 92.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.15 in the past 14 days, which was higher than the 7.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $132.88, while its 200-day Moving Average is $66.49. Nevertheless, the first resistance level for the watch stands at $201.28 in the near term. At $206.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $212.74. If the price goes on to break the first support level at $189.82, it is likely to go to the next support level at $183.19. Assuming the price breaks the second support level, the third support level stands at $178.36.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Key Stats
There are 25,007K outstanding shares of the company, which has a market capitalization of 4.91 billion. As of now, sales total 8,550 K while income totals -182,820 K. Its latest quarter income was 0 K while its last quarter net income were -73,930 K.
